Log in or Sign up for Free to view tailored content for your specialty!
Myeloproliferative Neoplasms News
Cancer mortality rates continue to decrease, but at a slower pace
Cancer mortality gradually declined over the past 2-plus decades, although the rate slowed between 2019 and 2022, according to results of the Annual Report to the Nation on the Status of Cancer.
Healio selected as CancerX 2025 Accelerator media partner
Healio is pleased to announce its partnership with CancerX, a public-private collaboration dedicated to the acceleration of innovation in cancer treatment.
VIDEO: Potential of mutant-specific therapeutics in myelofibrosis
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Novel therapies showing promise in myelofibrosis
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
VIDEO: Disease-modifying drugs needed in myelofibrosis
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
VIDEO: Recent approval ‘adds another option’ for patients with myelofibrosis
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
VIDEO: Expert discusses treatment options for myelofibrosis
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow disease, physicians reported Monday.
Time to vote: Healio | HemOnc Today announce 2025 Disruptive Innovators nominees
Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.
Healio seeks nominees for Disruptive Innovators in oncology/hematology
Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.
-
Headline News
Education increases odds parents will ask about guns in homes their kids visit
April 29, 20252 min read -
Headline News
BLOG: What to consider before signing a hospital employment, private practice contract
April 29, 20254 min read -
Headline News
‘Micro-communication’ behaviors can earn patient trust
April 29, 20253 min read
-
Headline News
Education increases odds parents will ask about guns in homes their kids visit
April 29, 20252 min read -
Headline News
BLOG: What to consider before signing a hospital employment, private practice contract
April 29, 20254 min read -
Headline News
‘Micro-communication’ behaviors can earn patient trust
April 29, 20253 min read